Dermata Therapeutics Inc (DRMA)
4.20
-1.00
(-19.23%)
USD |
NASDAQ |
May 17, 16:00
4.40
+0.20
(+4.76%)
After-Hours: 20:00
Dermata Therapeutics Total Assets (Quarterly): 5.180M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.180M |
| December 31, 2023 | 7.979M |
| September 30, 2023 | 7.323M |
| June 30, 2023 | 8.713M |
| March 31, 2023 | 9.295M |
| December 31, 2022 | 6.944M |
| September 30, 2022 | 8.975M |
| Date | Value |
|---|---|
| June 30, 2022 | 11.03M |
| March 31, 2022 | 9.044M |
| December 31, 2021 | 11.62M |
| September 30, 2021 | 13.69M |
| June 30, 2021 | 1.137M |
| March 31, 2021 | 1.651M |
| December 31, 2020 | 0.6055M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.6055M
Minimum
Dec 2020
13.69M
Maximum
Sep 2021
7.370M
Average
8.346M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.372M |
| Shareholders Equity (Quarterly) | 3.808M |